The

Best

Add Zone For You

sonikashukla98's blog

Bharat Book Bureau Provides the Trending Market Research Report on “Type2 Diabetes Mellitus- Pipeline Insight, 2022”under Pharmaceutical Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports.

Geography Covered
• Global coverage

Type2 Diabetes Mellitus Understanding

Type2 Diabetes Mellitus: Overview
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia. It may be due to impaired insulin secretion, resistance to peripheral actions of insulin, or both. Diabetes mellitus are of three types Type1, Type2 and Gestational Diabetes. Type 2 diabetes mellitus (T2DM) accounts for around 90% of all cases of diabetes. In T2DM, the response to insulin is diminished, and this is defined as insulin resistance. During this state, insulin is ineffective and is initially countered by an increase in insulin production to maintain glucose homeostasis, but over time, insulin production decreases, resulting in T2DM. T2DM is most commonly seen in persons older than 45 years. Type 2 diabetes primarily occurs as a result of obesity and lack of exercise. Some people are more genetically at risk than others. Type 2 diabetes makes up about 90% of cases of diabetes, with the other 10% due primarily to type 1 diabetes and gestational diabetes. Diagnosis of diabetes is by blood tests such as fasting plasma glucose, oral glucose tolerance test, or glycated hemoglobin (A1C). Type 2 diabetes is typically a chronic disease associated with a ten-year-shorter life expectancy.

"Type2 Diabetes Mellitus- Pipeline Insight, 2022" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Type2 Diabetes Mellitus pipeline landscape is provided which includes the disease overview and Type2 Diabetes Mellitus treatment guidelines. The assessment part of the report embraces, in depth Type2 Diabetes Mellitus commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Type2 Diabetes Mellitus collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Report Highlights
• The companies and academics are working to assess challenges and seek opportunities that could influence Type2 Diabetes mellitus R&D. The therapies under development are focused on novel approaches to treat/improve Postoperative Pain.

Type2 Diabetes mellitus Emerging Drugs Chapters
This segment of the Type2 Diabetes mellitus report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases.

Type2 Diabetes mellitus Emerging Drugs
• Sotagliflozin: Lexicon Pharmaceuticals
Sotagliflozin is an orally-delivered small molecule compound that we are developing for the treatment of heart failure and type 1 and type 2 diabetes. The scientists identified the targets of sotagliflozin, sodium-glucose cotransporter type 1, or SGLT1, and sodium-glucose cotransporter type 2, or SGLT2, in our target discovery efforts based on their discovery that mice lacking SGLT1, SGLT2 or both exhibited potent anti-diabetic phenotypes across multiple measures of glucose control and metabolism in preclinical models. Preclinical studies of sotagliflozin demonstrated that compounds inhibiting both targets had a favorable preclinical profile relative to compounds selective for SGLT2. SGLT1 is responsible for glucose absorption in the gastrointestinal tract, and SGLT2 is responsible for glucose reabsorption by the kidney. Sotagliflozin is in the phase 3 stage of development to treat Type 2 diabetes mellitus.

• ORMD0801: Oramed Pharmaceuticals
Oramed’s oral insulin (ORMD-0801) has the potential to create a new paradigm in the treatment of diabetes by oral delivery of insulin at an earlier stage of treatment, potentially slowing disease progression and delaying or even eliminating late-stage complications. Orally administered insulin brings with it enhanced patient compliance. In addition, intestinally absorbed-oral insulin actually mimics insulin’s natural location and gradients in the body by first passing through the liver before entering the bloodstream.ORMD0801 is in the phase 3 stage of development to treat Type 2 diabetes mellitus.

• LY3209590-Eli lily and Company
LY3209590 "Basal insulin-Fc" is a large molecule comprised of an engineered insulin fused to an Fc domain designed to provide a long-acting basal profile. LY3209590 is in Phase 2 stage of development for the treatment of Type2 diabetes.

• HM12460A: Hanmi Pharmaceuticals
The novel basal insulin HM12460A consists of an insulin analog (Insulin 115)conjugated to the human aglycosylated FC fragment via a small PEG linker and is developed for once-weekly administration HM12460A displays substantially prolonged pharmacokinetic and pharmacodynamic profile ,No increased mitogenic potency compared to regular insulin .It showed similar metabolic potency compared to regular insulin after long-term stimulation , decreased insulin receptor downregulation and it showed improved insulin signaling under chronic conditions.It is in Phase1 stage of development for the treatment of Type2 diabetes.

• HM14220:Hanmi Pharmaceuticals
HM14220 is a combination of a long-acting insulin analog and a long-acting exendin-4 analog; Targeting once weekly administration. It is in the pre-clinical stage of development for the treatment of Type2 Diabetes.
Further product details are provided in the report……..
Type2 Diabetes mellitus: Therapeutic Assessment

This segment of the report provides insights about the different Type2 Diabetes mellitus drugs segregated based on following parameters that define the scope of the report, such as:

• Major Players in Type2 Diabetes mellitus
There are approx. 100+ key companies which are developing the therapies for Postoperative Pain. The companies which have their Postoperative Pain drug candidates in the most advanced stage, i.e. phase III include, Lexicon Pharmaceuticals.

• Phases
DelveInsight’s report covers around 100+ products under different phases of clinical development like
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Type2 Diabetes mellitus pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal
• Molecule Type

Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule
• Product Type
Drugs have been categorized under various product types like Mono, Combination and Mono/Combination.

Type2 Diabetes mellitus: Pipeline Development Activities
The report provides insights into different therapeutic candidates in phase II, I, preclinical and discovery stage. It also analyses Type2 Diabetes mellitus therapeutic drugs key players involved in developing key drugs.

Pipeline Development Activities
The report covers the detailed information of collaborations, acquisition and merger, licensing along with a thorough therapeutic assessment of emerging Type2 Diabetes mellitus drugs.

Type2 Diabetes mellitus Report Insights
• Type2 Diabetes mellitus Pipeline Analysis
• Therapeutic Assessment
• Unmet Needs
• Impact of Drugs

Type2 Diabetes mellitus Report Assessment
• Pipeline Product Profiles
• Therapeutic Assessment
• Pipeline Assessment
• Inactive drugs assessment
• Unmet Needs

Key Questions
Current Treatment Scenario and Emerging Therapies:
• How many companies are developing Type2 Diabetes mellitus drugs?
• How many Type2 Diabetes mellitus drugs are developed by each company?
• How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Type2 Diabetes mellitus?
• What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Type2 Diabetes mellitus therapeutics?
• What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Type2 Diabetes mellitus and their status?
• What are the key designations that have been granted to the emerging drugs?

Key Players
Hanmi Pharmaceuticals
• Sanofi
• Eli lily and Company
• AstraZeneca
• NovoNordisk
• Noxxon Pharma AG
• Oramed Pharmaceuticals
• Lexicon Pharmaceuticals
• Daiichi Sankyo Company
• Halozyme Therapeutics
• Saniona
• Novartis
• Pfizer
• Merck Sharp & Dohme Corp.
• Mylan
• Nordic Bioscience A/S
• KeyBioscience AG
• Adocia
• Jiangsu Hengrui Medicine
• Bristol myers Suibb
• Phenomix
• Forest Laboratories
• ACADIA Pharmaceuticals
• Hanmi Pharmaceuticals
• Cytogel
• Ligand Pharmaceuticals
• Arthritis Innovation Corporation
• Astellas Pharma
• IItoo Pharma
• Medspace Inc.
• Oramed Ltd.
• Flexion Therapeutics
• Integrium
• AbbVie

Key Products
• ORMD0801
• HumalogU-100
• Sotagliflozin
• Exenatide
• Topiramate
• LY3209590
• HM12460A
• HM14220
• Tesofensine/Metoprolol
• Ruboxistaurin Mesylate
• BMS-816336
• Atrasentan
• Inhaled Human Insulin
• Human regular U-500 insulin
• Humalog
• Insulin Glargine
• Tirzepatide
• Oxyntomodulin

Browse our full report with Table of Content : https://www.bharatbook.com/report/1339689/type-diabetes-mellitus-pipeline-insight

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

Bharat Book Bureau Provides the Trending Market Research Report on “Online Grocery Market - Global Outlook and Forecast 2022-2028”under Consumer Goods Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports.

Online grocery refers to the purchase of fresh and packaged food through online portals. Ways of buying groceries have evolved over a period of time, owing to easy availability of products through stores and online platforms.
This report contains market size and forecasts of Online Grocery in Global, including the following market information:

Global Online Grocery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Online Grocery market was valued at 52000 million in 2021 and is projected to reach US$ 135340 million by 2028, at a CAGR of 14.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Packaged Foods Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Online Grocery include Carrefour, Kroger, Tesco, Walmart, Amazon, Target, ALDI, Coles Online and BigBasket, etc. In 2021, the global top five players have a share approximately % in terms of revenue.


Our Research has surveyed the Online Grocery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Online Grocery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Online Grocery Market Segment Percentages, by Type, 2021 (%)
Packaged Foods
Fresh Foods
Global Online Grocery Market, by End User, 2017-2022, 2023-2028 ($ millions)
Global Online Grocery Market Segment Percentages, by End User, 2021 (%)
Personal Shoppers
Business Customers
Global Online Grocery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Online Grocery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Online Grocery revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Online Grocery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Carrefour
Kroger
Tesco
Walmart
Amazon
Target
ALDI
Coles Online
BigBasket
Longo
Schwan Food
FreshDirect
Honestbee
Alibaba

Browse our full report with Table of Content : https://www.bharatbook.com/report/1265467/online-grocery-market-global-outlook-and-forecast

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

Bharat Book Bureau Provides the Trending Market Research Report on “United States Online Grocery Market Size, Share, Emerging Trends, Current Analysis, Growth, Demand, Opportunity, and Forecast 2022 – 2028”under Consumer Goods Market Research Report Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Amid the COVID-19 crisis, the United States market for online grocery estimated at US$ 96 billion in the year 2021, is expected to reach a revised market size of US$ 242 billion by 2028, growing at a CAGR of 14.1% over the period 2021 - 2028.

The Prominent Factors that are Expected to Contribute to the Growth of the United States Online Grocery Market During the Forecast Period:
• changing lifestyle of the consumers
• tech-savvy generation who prefers buying products online
• the growth in disposable incomes and busier lifestyles
• The preference for online delivery of grocery products became more visible following the COVID-19 outbreak

After conducting thorough research on the historical and current growth parameters, the growth prospects of the United States Online Grocery Market are obtained with maximum precision.

This new 2022 market report provides a holistic analysis of the entire United States online grocery market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the United States' online grocery market. The report also provides up–to–date historical market size data for the period 2019 – 2021 and an illustrative forecast to 2028 covering key market aspects like market value and volume for online grocery in the United States.

The report provides in-depth analysis, information, and market size of the major 8 segments from 2019 to 2021, and forecasts to 2028. A comprehensive analysis has been done on market share with the percentage of the major segments and key players.

The report also covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

The report will serve as a source for a 360-degree analysis, thoroughly integrating different models.

This Newest and Comprehensive the United States Online Grocery Market Research Report 2022 Delivers:
• Comprehensive Research Methodology of the United States Online Grocery Market
• Insights about Market Determinants that are Stimulating the United States Online Grocery Market
• To Analyse the Historical Growth in the Market Size of the United States Online Grocery Market from 2019 to 2021
• To Estimate and Forecast the Market Size of the United States Online Grocery Market from 2022 to 2028 and Growth Rate until 2028
• The Market Size of the United States Online Grocery Fruits and Vegetables with Six Years Forecast
• The Market Size of the United States Online Grocery Frozen Foods with Six Years Forecast
• The Market Size of the United States Online Grocery Drugs and Healthcare Items with Six Years Forecast
• The Market Size of the United States Online Grocery Meat, Fish, Poultry and Other Deli Items with Six Years Forecast
• The Market Size of the United States Online Grocery Beverages (including Alcohol) with Six Years Forecast
• The Market Size of the United States Online Grocery Dairy Products with Six Years Forecast
• The Market Size of the United States Online Grocery Other Non-Foods Items with Six Years Forecast
• The Market Size of the United States Online Grocery Other Foods with Six Years Forecast
• Extensive Profiles and Recent Developments of 7 Market Players.

Key Market Segmentation:
This report provides an analysis of the key trends in each segment of the United States Online Grocery market report, along with forecasts for growth from 2022 to 2028.
• Fruits and Vegetables
• Frozen Foods
• Drugs and Healthcare Items
• Meat, Fish, Poultry, and Other Deli Items
• Beverages (including Alcohol)
• Dairy Products
• Other Non-Foods Items
• Other Foods

The Key Market Players for the United States Online Grocery Market are Listed Below:
• Walmart
• The Kroger Co.
• Target Brands, Inc.
• Amazon.com, Inc.
• Albertsons Companies Inc.
• Fresh Direct (Ahold Delhaize)
• Costco Wholesale Corporation

Key Questions Answered in this Report:
• What is the current scenario of the United States online grocery market?
• What is the total market size and forecast (until 2028) for the United States online grocery market?
• How big is the United States online grocery market?
• What are the market shares of the leading segments of the United States online grocery market?
• What are the main segments within the overall United States online grocery market? How much will each of these segments be worth for the period 2019 to 2028?
• What are the major drivers of the United States online grocery market?
• What are the major inhibitors of the United States online grocery market?
• Who are the top market players? What are their happenings, current developments, and scenarios?
• How is the market predicted to develop in the future?

Browse our full report with Table of Content : https://www.bharatbook.com/report/1339886/united-states-online-grocery-market-size-share-emerging-trends-current-analysis-growth-demand-opportunity-and-forecast

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 6,50,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

Bharat Book Bureau Provides the Trending Market Research Report on “Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2028”under Life Sciences Market Research Report Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2028 Report Highlights:
• Global Nanoparticle Drug Delivery Market Opportunity > USD 300 Billion by 2028
• Nanoparticle Drug Deliver Price & Dosage Insight By Therapeutic: Cancer, Anemia, Autoimmune Diseases, Neurological Disorders
• Global Nanoparticle Drug Market Regional Analysis: US, Europe, China, Japan, India, Taiwan, South Korea, Canada
• Nanoparticle Therapeutics Approved Drugs Sales Insight: 15 Drugs
• Nanoparticle Therapeutics Approved Drugs Sales Forecast 2028: 15 Drugs
• Global Nanoparticle Drugs Clinical Pipeline Insight By Phase, Company & Indication: > 400
Drugs• Nanoparticle Drug Delivery - Market Trend & Patent Distribution Analysis

During the last few decades, there has been enormous development in the field of delivery systems to provide therapeutic agents or natural based active compounds to the target location for the management of several diseases. Several drug delivery approaches have been successfully employed in recent times, however there are still certain challenges that need to be addresses and an advanced technology need to be developed for successful delivery of drugs to its target sites. In order to overcome these challenges, the nanoparticle based drug delivery systems are currently been studied that will facilitate the advanced system of drug delivery.

Nanoparticle drug delivery is the emerging branch which utilizes nanotechnology in the prevention and treatment of various diseases using the nanoscale materials, such as biocompatible nanoparticles and nanorobots for delivery of drug to target location. Several biopolymeric nanoparticles can be utilized for drug delivery systems such as chitosan, xanthum gum, cellulose, liposome, dendrimers, and others. Liposome drug delivery approach is one of the most promising approaches and held the maximum share in the global nanoparticle drug delivery market.

Companies in the liposome drug delivery market are increasing their focus on drug delivery nanosystems involving major antiviral classes and their transport across specific barriers at cellular and intracellular levels. Thus, liposomes hold promising potentials in ongoing research studies being carried out by healthcare companies for the treatment of coronavirus. Further, several pharmaceutical companies have also entered into collaboration or partnerships to drive this segment in forecast period.
For instance, Encapsula NanoSciences has extensive collaboration with academic research laboratories and is currently working with synthetic chemists and cancer biologists at a major university in the development of new anti-tumor compounds that require a liposome delivery system to be dosed in vivo. Moreover, Lipella Pharmaceuticals Inc. has been funded by the National Institutes of Health Small Business Innovation and Research (SBIR) to develop intravesical liposome nanoparticles to treat overactive bladder (OAB), interstitial cystitis/painful bladder syndrome (IC/PBS).

Apart from oral drugs, researchers have also expanded the idea of nanotechnology towards vaccine development. So far, two nanoparticle formulated, mRNA based COVID-19 vaccines have been developed, clinically tested and marketed during the ongoing pandemic. These vaccines are BNT162b2 by Pfizer/BioNTech and mRNA-1273 by Moderna. Apart from this, two vaccines are present under development such as NVX-CoV2373 vaccine (Novavax).

Further to mitigate the high cost associated with nanoparticle drugs, the research is also directed towards the development of cost-effective nanoparticle based generic drugs. The generic nanoparticle drug has also seen substantial rise in production as they are less expensive than branded and do not require extensive research and testing. Several pharmaceutical companies including Mylan, Teva, Actavis, Lupin Laboratories, Sun Pharma, and others have launched their generic versions in the market, which have shown high acceptance.

As per our report findings, the global nanoparticle drug delivery market is expected to surpass US$ 300 Billion by 2028. The market has high potential for growth which is attributed to the increasing number of patients suffering from chronic diseases, increasing research and development spending by pharmaceutical giants in the region with a robust clinical pipeline of nanoparticle drug delivery systems. In addition, the rising disposable population leading to increasing awareness towards health and lifestyle is also likely to propel the market growth. Further, the availability of wide range of generic drugs which increasing the accessibility among general population also propels the growth of market during the forecast period.

The report Nanoparticle drug delivery market provides comprehensive analysis on the commercially available nanomedicines along with their price, dosage, generic availability, and sales analysis. Moreover, in-depth analysis on the ongoing clinical trials in the report is also included in the report. Further, key players and their strategies are thoroughly analyzed to provide competitive outlook to the industry.

Browse our full report with Table of Content : https://www.bharatbook.com/report/1339877/global-nanoparticle-drug-delivery-market-dosage-price-and-clinical-pipeline-outlook

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

Bharat Book Bureau Provides the Trending Market Research Report on “Vietnam E-Pharmacy Market, By Product Type (Prescription Medicines v/s Over-The-Counter Medicines), By Therapy Area (Vitamins, Dermatology, Cold & Flu, Weight Loss, Others), By Operating Platform (Websites v/s Apps), By Region, Competition Forecast & Opportunities, 2027”under Healthcare Services Market Research Report Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Vietnam E-Pharmacy Market was valued at USD72.06 million in the year 2021, that may register its growth at a CAGR of 22.85% during the forecast period, 2023-2027, to achieve a market value of USD242.1 million by 2027F on the account of expanding pharmaceutical industry in the country. Growing penetration of internet in the healthcare industry and distribution of the pharmaceutical and therapeutic products over online channels, is anticipated to drive the growth of the Vietnam E-Pharmacy Market in the upcoming five years. Digitization of healthcare services along with the increasing e-commerce adaptations by the market players for the sales of the product all over the country us further supporting the growth of the Vietnam E-Pharmacy Market in the next five years. Recent pandemic situation due to COVID-19, further enhanced on the e-commerce industry.

The consumers preferred online purchases and home delivery of the medical supplies like medicines, masks, sanitizers, etc. over physically visiting the pharmacies. The inclination toward online shopping further enhanced the growth of the Vietnam E-Pharmacy Market in the future five years. Moreover, increasing sales of smartphones, increasing use of internet based services of pharmaceuticals and therapeutics is further substantiating the growth of the Vietnam E-Pharmacy Market in the forecast years through 2027. Surging demand for over the counter drugs along with the efficiency of the e-pharmacies in delivering low cost medical supplies for the population is further aiding the growth of the Vietnam E-Pharmacy Market in the forecast period.

The Vietnam E-Pharmacy Market is segmented by product type, therapy area, operating platform, competitional landscape, and regional distribution. Based on product type, the market is further differentiated into prescription medicine and over the counter drugs. Prescription drugs are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on the ground of rapidly increasing instances of chronic diseases in the country.

Prolonged treatment for the diseases requires regular drugs dosage that drives the consumer to continue purchasing the drugs from online pharmacies thus driving the growth of the market segment. Over the counter drugs are also expected to hold significant revenue shares of the market and aid the market growth with increasing sales. Rapidly growing lifestyle diseases due to increasing cases of obesity, blood pressure, diabetes, etc. along with the other age related disorders are driving the growth of the Vietnam E-Pharmacy Market in the forecast years through 2027. Increasing geriatric population of the country also influences the growth of the Vietnam E-Pharmacy Market in upcoming five years.
Medcare Services and Investment Co., TNHH Buymed Co., Ltd., FPT Long Chau Pharma Joint Stock Company, Phòng khám Đa khoa Cao Cấp Jio Health (Jio Health), Med247, Vietskin (Gia Han Medical Services Joint Stock Company), Nhà thuốc Pharmacity, Medigo Vietnam, mClinica Vietnam, VinFa Joint Stock Company, among others is a partial list of major market players of the companies responsible for the growth of Vietnam E-Pharmacy Market.

Years considered for this report:
Historical Years: 2017- 2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023 – 2027

Objective of the Study:
•To analyze the market size of Vietnam E-Pharmacy Market from 2017 to 2020.
•To estimate and forecast the market size of Vietnam E-Pharmacy Market from 2021 to 2022 and growth rate until 2027.
•To classify and forecast Vietnam E-Pharmacy Market based on product type, therapy area, operating platform, competitional landscape, and regional distribution.
•To identify dominant region or segment in the Vietnam E-Pharmacy Market.
•To identify drivers and challenges for Vietnam E-Pharmacy Market.
•To examine competitive developments such as expansions, new service launches, mergers & acquisitions, etc., in Vietnam E-Pharmacy Market.
•To identify and analyze the profile of leading players operating in Vietnam E-Pharmacy Market.
•To identify key sustainable strategies adopted by market players in Vietnam E-Pharmacy Market.

Browse our full report with Table of Content : https://www.bharatbook.com/report/1339804/vietnam-e-pharmacy-market-by-product-type-prescription-medicines-vs-over-the-counter-medicines-by-therapy-area-vitamins-dermatology-cold-flu-weight-loss-others-by-operating-platform-websites-vs-apps-by-region-competition-forecast-opportunities

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

Bharat Book Bureau Provides the Trending Market Research Report on“Global Immune Checkpoint Inhibitors Biomarkers & Clinical Trials Insight 2028 "under Life Sciences Market Research Report Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Global Immune Checkpoint Inhibitors Biomarkers and Clinical Trials Insight 2028 Report Highlights:

Global Immune Checkpoint Inhibitors Market Opportunity: > USD 30 Billion
Immune Checkpoint Inhibitors Clinical Trials Insight: CTLA-4, LAG3, PD-1/PD-L1, TIGIT Inhibitors
Immune Checkpoint Inhibitors Clinical Trials Insight: > 300 Drugs In Trials
Biomarkers Insight By Immune Checkpoint Inhibitors Classification
Insight On Biomarkers Sourced From Trials By Drugs and Indication
Biomarker Name and Function Insight By Immune Checkpoint Inhibitor Drug
Biomarker Insight Based On Drugs In Multiple Trials Phase and Multiple Indication
Cancer biomarker is a traceable substance or molecules which indicate the presence of cancerous cells. The prevention of cancer by diagnosing and analyzing various cancer biomarkers using different diagnostic techniques is a profound approach to obtain rapid results for treatment. There are various types of biomarkers such as proteins, peptides, antibodies, and nucleic acids. The presence of these biomarkers in tissues, urine, serum, blood, and other body fluids indicate an abnormal process or a disease.

Various such biomarkers for cancer indications have been studied and are used as biomarkers for diagnostics, prognostics, personalized medicines, and surrogate endpoints. The identification of different types of biomarkers is an integral part of various industries such as healthcare and pharmaceuticals.

Among all targeted approaches, immune checkpoint inhibitors have gained the maximum interest in the market. To date, several immune checkpoint inhibitors have entered the market and various others are present in clinical development, thus driving this sector during the forecast period. However, these immune checkpoint inhibitors are shown to be effective in about 20%-30% of the cancer patients. Therefore, there is unmet need to develop and validate accurate biomarkers to assist immune checkpoint therapy in cancer patients.

Currently, the FDA has approved three predictive biomarkers for immune checkpoint inhibitor therapy in cancer patients including programmed cell death ligand-1 (PD-L1); microsatellite instability (MSI), and tumor mutational burden (TMB). Apart from this, several others are present in clinical development. The report provides comprehensive analysis on the ongoing clinical trials related to biomarker for approved immune checkpoint inhibitors as well as inhibitors which are under clinical trials. Furthermore, the role of biomarker in different therapeutic conditions is also mentioned in the report.

Many pharmaceutical companies are actively investing in research and development of novel biomarkers for the diagnosis and treatment of cancer. Many potential candidates are in their end stage of development and are projected to give a tremendous boost to the market after their launch.
Recently in 2022, Personalis announced a strategic alliance with the Moores Cancer Center at University of California San Diego Health, a National Cancer Institute-designated Comprehensive Cancer Center, to support clinical diagnostic testing in patients with advanced solid tumors and hematological malignancies. The collaboration will bring Personalis’ leading comprehensive genomic tumor profiling test to UC San Diego health care professionals and their cancer patients to help guide FDA-approved therapy decisions, as well as clinical trial treatment options.

The US will continue to dominate the global market in terms of biomarker research and Immune checkpoint inhibitor sales during the forecast period driven by several factors including higher adoption of advanced technologies like next generation sequencing, and the increasing number of research studies establishing the role of biomarkers in drug discovery and development, and cancer diagnosis. Additionally, rising prevalence of cancer in the region and surge in awareness among population regarding the availability of biomarkers will also aid in the growth of market.
Furthermore, rapid approval of diagnostic tests in the region will also propel the growth of the market. For instance in 2022, Oxford BioDynamics announced the US launch of its checkpoint inhibitor test (EpiSwitch CIRT) for cancer.

The global immune checkpoint inhibitor biomarkers market is expected to witness a significant growth during the forecast period due to increase in prevalence of various types of cancers such as breast, prostate, and lung cancer. In addition, surge in importance of biological and targeted drug therapies, technological advancements, accuracy, and reliability of cancer biomarkers also contribute toward the growth of the market.

Moreover, increase in investments from governments and public and private sector toward research and development for cancer diagnostics have a positive impact on the market. The key players in the market include Roche, Abbott, Thermo Fisher Scientific, Centogene, Myriad, and others.

Browse our full report with Table of Content :
https://www.bharatbook.com/report/1339740/global-immune-checkpoint-inhibitors-biomarkers-clinical-trials-insight

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 7,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: http://www.bharatbook.com

Bharat Book Bureau Provides the Trending Market Research Report on “Global Fertilizer Market Outlook, 2027”under Agriculture Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports.

According to the report title “Global Fertilizer Market Outlook, 2027”, published by Our Research, the consumption of the Global Fertilizer Market is expected to reach more than $260 Billion by the year 2027. In volume terms, nitrogenous fertilizer has the highest market share, followed by phosphate and Potash fertilizer. The majorly consumed fertilizers are Urea, DAP, MAP, MOP, and Complex.

Asia-Pacific has the largest fertilizer market in terms of both by value & by volume followed by Europe and North America. In nitrogenous fertilizer, Asia-Pacific covers around half of the market share worldwide. On the other hand North America, Latin America & MEA contributes more than 25% of the market share. China is the market leader followed by India, USA, & Brazil. Canada is the largest producer and exporter of Potash fertilizer while the USA consumes most of the potash fertilizer. In complex fertilizer India & Russia has a remarkable market share.

Fertilizer applications are dependent on the need of nutrients by plants. The most important nutrient is nitrogen. The fertilizers are majorly consumed by these categories like fruits & vegetables, oilseeds & pulses, cereals & grains and other plants. The majority of fertilizers are used in the production of vegetables/fruits and cereals/pulses with around 70-80% market share. Latin America has different scenario in consumption of fertilizer by application compared to Europe and Asia-Pacific. Each fertilizer product has its own benefits though complex fertilizer leads with the highest market share followed by Urea, DAP and MOP into global fertilizer consumption. Argentina leads in MAP fertilizer while Saudi Arabia leads in DAP fertilizer’s market share in the phosphate fertilizer segment. Most of the fertilizers are consumed by Wheat, rice, maize, soybean, vegetable, sugar crops, fruits and other food crops.

Plants provide food, fiber, shelter and a host of other welfare and fertilizer plays a significant role in this process. The world’s population is expected to increase by 2 billion persons in the next 30 years, from 7.7 billion currently to 9.7 billion in 2050 (Source: United Nations). So in order to fulfill the increased global food demand fertilizers will be needed more than ever to boost crop production to keep people fed and healthy. A fertilizer is a product containing various types of nutrients by which plants can grow more efficiently. Crop nutrients not only enhance the growth of plants but also aid the fertility of the soil with various numerous minerals and other elements. It is available in varied forms like solid and liquid. The market has distinct types of fertilizers available specific to their need, so it is beneficial to have in-depth knowledge of their types before utilizing them. The chemical fertilizer is mainly sub-divided into three major nutrients as Nitrogenous fertilizer, Phosphate fertilizer & Potash fertilizer. The complex fertilizer has its own dominance because it contains two or more than two nutrients within it in order to provide multiple nutrients and solutions.

COVID-19 Impact:
The fertilizer industry has not been significantly affected by COVID-19 because many countries have exempted the segment during the lockdown period. Though the lack of the supply of raw materials & manpower the market had gotten away from it y-o-y growth. The economic issues are now being felt in the regions where the coronavirus is increasing, such as Asia, America and Europe. During the COVID-19 the fundamentals of the fertilizer industry are strong even during the crisis. The demand is driven by the increasing use of crop nutrients in crop production to fulfill the growing food demand. There are some crucial factors for stable global fertilizer consumption like population growth, growth of the world GDP, alternative uses of crops, etc. So in order to maintain the growth of the current and future coming problems the agriculture’s R&D departments are persevering.

Major Companies present in the market:
The Mosaic Company, Yara International, Nutrien Limited, K+S Aktiengesellschaft, OCP Group, CF Industries Holdings, Sociedad Química y Minera de Chile (SQM), National Fertilizers Limited Coromandel International Limited, EuroChem Group, Wesfarmers, Indian Farmers Fertilizer Co-operative Limited (IFFCO)

Considered in this report
• Geography: Global
• Historic Year: 2016
• Base year: 2021
• Estimated year: 2022
• Forecast year: 2027

Aspects covered in this report
• Global fertilizer market with its value and forecast along with its segments
• Region & country wise fertilizer market analysis
• Application wise fertilizer consumption
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions covered in the report
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle-East & Africa

Types of fertilizer by nutrient in the report:
• Nitrogenous fertilizer (Urea, ammonium sulphate, Calcium ammonium nitrate/ ammonium nitrate, others UAN, anhydrous ammonia etc.)
• Phosphate fertilizer (Diammonium phosphate, monoammonium phosphate, others phosphate rock, superphosphates etc.)
• Potash fertilizer (Muriate of potash/potassium chloride, sulphate of potash others potassium nitrate etc.)
• Complex fertilizer (NPK, NK, PK, NP compounds etc.)

By Product type in the report:
• Urea
• Ammonium sulphate
• Calcium ammonium nitrate/ Ammonium nitrate
• Di-ammonium phosphate (DAP)
• Mono-ammonium phosphate (MAP)
• Muriate of potash (MOP)/ (KCl)
• Sulphate of potash (SOP)
• Complex (NPK, NK, PK, NP)

By physical formulation in the report:
• Dry
• Liquid

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third party sources such as press releases, annual report of companies, analysing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to fertilizer industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

Browse our full report with Table of Content :
https://www.bharatbook.com/report/1339639/global-fertilizer-market-outlook

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

Bharat Book Bureau Provides the Trending Market Research Report on “Global Electric Motorcycle Market, Segmented By Type (Standard, Cruiser, Sports), By Range (Less than 50 Km, 50–100 Km, 101–150 Km, Above 150 Km), By Battery Capacity (<25 Ah and >25 Ah), By Battery Type (Lead Acid and Li-ion), By Region, Competition Forecast and Opportunities, 2026”under Automotive Market Research Report Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Global Electric Motorcycle Market was valued at USD1930.64 million in 2020 and is anticipated to grow with a CAGR of 19.36% in the forecast period, 2022-2026, to reach USD6220.82 million by 2026. The market growth can be attributed to the factors like increasing demand for sustainable transportation. Also, rising awareness among the population regarding depleting environment and the advantages of electric motorcycles for the betterment of the environment further drives the growth of the global electric motorcycle market in the upcoming five years. Additionally, the COVID-19 pandemic situation played a vital role in increasing the demand for the electric motorcycle market.

This image has an empty alt attribute; its file name is electric-motorcycle-market.jpg

Pandemic halted the manufacturing of vehicle components and OEM parts and available electric motorcycles in the market became the first choice among the consumers, owing to the demand for personal vehicles in an affordable range. Moreover, expanding dealer and distributor network promoting the electric vehicle and its advantages is further supporting the growth of the global electric motorcycle market in the next five years. Consistent research and technological advancements in the automobile industry to provide more advanced technologies to electric motorcycles further substantiate the growth of the global electric motorcycle market in the future five years.

Furthermore, increasing government investment, private funding, foreign direct investments, along with favorable schemes and initiatives from the government in electric motorcycles are also some of the major factors behind the growth of the global electric motorcycle market in the forecast years until 2026.

The global electric motorcycle market is segmented by type, range, battery capacity, battery type, regional distribution, and competitive analysis. On the basis of type, the market is segmented into standard, cruiser and sports. Standard electric motorcycle type is anticipated to dominate the market and hold the largest revenue shares of the market in the upcoming five years on the grounds of affordability of the product. Moreover, standard types have more models and variants for consumers to choose from. Whereas in cruiser or sports motorcycles, limited number of models and variants are available. Also, cruiser or sports motorcycles are targeted towards a specific line of customers. Travelers and racers prefer cruiser and sports motorcycles, but a large number of customers prefer standard motorcycles, thus driving the growth of the global electric motorcycle market along with the sub-segment in the next five years.

Zero Motorcycles, Inc., Kwang Yang Motor Co., Ltd, Hero Electric Vehicles Pvt. Ltd., Energica Motor Company S.P.A., Terra Motors Corporation, Harley-Davidson, Inc., H-D, ARC Vehicles Ltd, Damon Motors Inc, Lightning Motorcycle Corp., Johammer e-mobility GmbH, and VMOTO LIMITED. These key players are developing advanced technologies to stay competitive in the market and enhancing their product portfolio in the regions to increase their customer outreach.

Years considered for this report:
Historical Years: 2016-2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022–2026

Objective of the Study:
•To analyze the historical growth in the market size of global electric motorcycle market from 2016 to 2020.
•To estimate and forecast the market size of global electric motorcycle market from 2021 to 2026 and growth rate until 2026.
•To classify and forecast global electric motorcycle market based on type, range, battery capacity, battery type, regional distribution, and competitive analysis.
•To identify dominant region or segment in the global electric motorcycle market.
•To identify drivers and challenges for global electric motorcycle market.
•To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global electric motorcycle market.
•To identify and analyze the profile of leading players operating in global electric motorcycle market.
•To identify key sustainable strategies adopted by market players in global electric motorcycle market.

Our Research performed both primary as well as exhaustive secondary research for this study. Initially, Our Research sourced a list of manufacturers across the globe. Subsequently, Our Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Our Research could include the manufacturers which could not be identified due to the limitations of secondary research. Our Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
Our Research calculated the market size of global electric motorcycle market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Our Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by Our Research.

Key Target Audience:
•Manufacturers, suppliers, distributors and other stakeholders
•Government bodies such as regulating authorities and policy makers
•Organizations, forums and alliances related to electric motorcycles
•Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global electric motorcycle market.
Available Customizations:
With the given market data, Our Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).
A FORMAT

Browse our full report with Table of Content : https://www.bharatbook.com/report/1290854/global-electric-motorcycle-market-segmented-by-type-standard-cruiser-sports-by-range-less-than-km-km-km-above-km-by-battery-capacity-ah-and-ah-by-battery-type-lead-acid-and-li-ion-by-region-competition-forecast-and-opportunities

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

Show Your Work Here .Whatsapp 9301837771

Alexa Global Rank 99000

google ranking checker website hit counter

Sales

Manager